Estadístiques de Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS)
Visites totals
| views | |
|---|---|
| Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS) | 63 |
Visites totals per mes
| views | |
|---|---|
| July 2024 | 0 |
| August 2024 | 6 |
| September 2024 | 4 |
| October 2024 | 0 |
| November 2024 | 1 |
| December 2024 | 0 |
| January 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| Grivas_bmc_effi.pdf(legacy) | 67 |
| Grivas_bmc_effi.pdf | 2 |
Vistes principals per país
| views | |
|---|---|
| United States | 49 |
| Spain | 3 |
| Belgium | 2 |
| Germany | 2 |
| France | 2 |
| Argentina | 1 |
| Ireland | 1 |
| India | 1 |
| Iran | 1 |
| Malaysia | 1 |
Visites principals per ciutat
| views | |
|---|---|
| San Ramon | 18 |
| Ann Arbor | 6 |
| Menlo Park | 5 |
| Mountain View | 5 |
| Fairfield | 3 |
| Barcelona | 2 |
| Boardman | 2 |
| Cambridge | 2 |
| Falls Church | 2 |
| San Diego | 2 |
| Ashburn | 1 |
| Dresden | 1 |
| Dublin | 1 |
| Plankstadt | 1 |
| Sacramento | 1 |
| Shah Alam | 1 |
| Suipacha | 1 |
| Thane | 1 |